Arcade (20090160): A phase 3 randomized placebo-controlled double-blind trial of darbepoetin alfa in the treatment of anemia in patients with low or intermediate-1 risk myelodysplastic syndromes (MDS)

Authors
Category Primary study
JournalHaematologica
Year 2016
This article has no abstract
Epistemonikos ID: f09be83646b70b5dcfe07b7b7886a3735b2bf95f
First added on: Feb 08, 2025